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doi:10.1016/j.ejvs.2011.11.007Letter to Editor Re “Differential Protein Expression in Serum of
Abdominal Aortic Aneurysm Patients – A Proteomic Approach”Dear Editor,
In their paper “Differential expression in serum of abdominal
aortic aneurysm patients – A proteomic approach”, Pulinx et al.1
mined the proteome of patients with AAAs in search of novel
biomarkers. They report elevated factor XII and a-1 antitrypsin
levels in the serum of patients with progressive aneurysms, but
found these proteins to have little ability to predict aneurysm
progression above the established marker, AAA diameter.
I propose that the authors were never likely to discover a puta-
tive biomarker using this technique. DIGE has been utilised by
scientists across medicine and vascular surgery [including our
group] for many years, and although it has provided insight into
disease pathogenesis, it has failed to discover a biomarker translat-
able to clinical practice.2
Serum is an unstable sensitive protein preparation, which can
modify depending on harvest factors including time-of-day,
ambient temperature, current health, sex, and age, all factors which
have not been controlled for in this study.3 Given this principle ﬂaw,
and the most signiﬁcant ﬁnding being increased expression of
ubiquitous Albumin in patients with large AAAs [P ¼ 0.007], the
results must be interpreted with caution.
I do acknowledge the authors correct closing comments that
“further research, with larger sample sizes” are appropriate. It
should be emphasised that this should be in the form of a multi-
centre, prospective, protocol driven study using blood plasma
[a more stable protein suspension]. The analysis should utilise
high-throughput proteomic techniques obviating the potential
confounders caused by protein fractionation and enrichment that
limit DIGE.DOI of original article: 10.1016/j.ejvs.2011.11.024.References
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doi:10.1016/j.ejvs.2011.11.021Response to Letter to Editor re “Differential Protein Expression
in Serum of Abdominal Aortic Aneurysm Patients – A
Proteomic Approach”Dear Editor,
We would like to thank Dr. Nordon for his interest in
and remarks on our manuscript. We fully agree that the transla-
tion of proteomics-discovered biomarkers into clinically mean-
ingful assays is difﬁcult. However, our aim was to ﬁnd
differential protein expression related to aneurysm size and
progression. These differentially expressed proteins could
help to elucidate the mechanisms behind abdominal aortic
aneurysm.
Furthermore, standardization of sample collection and process-
ing procedures is crucial, since they can have a dramatic effect on
quality and reproducibility of the obtained results. To obtain
comparable and reproducible results, we collected, processed and
stored all our samples in a highly standardized way. Indeed, it is
known that age, sex and several other factors can inﬂuence the
protein expression pattern in serum. Therefore, we used linear
regression to control for possible bias due to age, sex and peripheral
arterial disease (PAD) and our found associations remained
signiﬁcant.
As Dr. Nordon correctly emphasizes, further research with larger
sample sizes is necessary. Therefore, we are still including AAA
patients in a standardized follow-up regime. We are planning to
analyze the protein expression patterns in serum, EDTA plasma as
well as citrate plasma.B. Pulinx
Department of Clinical Chemistry, Maastricht University
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